QIAGEN N.V. (QGEN)

Price$41.04

Favorite Metrics

Price vs S&P 500 (26W)-19.98%

Price vs S&P 500 (4W)-4.21%

Market Capitalization$8.46B

P/E Ratio (Annual)19.91x

Indicated Dividend Yield (Annual)0.64%

All Metrics

P/CF (Annual)12.93x

Book Value / Share (Quarterly)$17.45

P/TBV (Annual)2.88x

Indicated Dividend (Annual)$0.25

Revenue Growth (3Y)-0.81%

Cash Flow / Share (Quarterly)$2.06

Price vs S&P 500 (YTD)-12.67%

Gross Margin (TTM)62.99%

Net Profit Margin (TTM)20.33%

EPS (TTM)$2.00

10-Day Avg Trading Volume1.40M

EPS Excl Extra (TTM)$2.00

Revenue Growth (5Y)2.25%

EPS (Annual)$1.94

Dividend / Share (Annual)$0.25

ROI (Annual)7.82%

Gross Margin (Annual)63.67%

Net Profit Margin (5Y Avg)16.89%

Cash / Share (Quarterly)$5.07

P/E Basic Excl Extra (TTM)19.91x

Revenue Growth QoQ (YoY)3.69%

EPS Growth (5Y)4.22%

P/E Normalized (Annual)19.91x

ROA (Last FY)6.76%

Revenue Growth TTM (YoY)5.65%

EBITD / Share (TTM)$2.20

ROE (5Y Avg)10.26%

Operating Margin (TTM)22.17%

Cash Flow / Share (Annual)$2.06

P/B Ratio2.24x

P/B Ratio (Quarterly)2.58x

Net Income / Employee (Annual)$0

EV / Revenue (TTM)4.44x

Net Interest Coverage (TTM)27.84x

ROA (TTM)7.02%

EPS Growth QoQ (YoY)25.45%

EV / EBITDA (TTM)19.78x

EPS Incl Extra (Annual)$1.94

Current Ratio (Annual)3.90x

Quick Ratio (Quarterly)2.95x

3-Month Avg Trading Volume2.06M

52-Week Price Return0.81%

EV / Free Cash Flow (Annual)20.74x

P/E Incl Extra (TTM)19.91x

Revenue / Employee (TTM)$0

Tangible BV / Share (Quarterly)$15.66

P/S Ratio (Annual)4.05x

Asset Turnover (Annual)0.33x

52-Week High$57.81

Operating Margin (5Y Avg)20.11%

EPS Excl Extra (Annual)$1.94

CapEx CAGR (5Y)-7.40%

Tangible BV CAGR (5Y)10.36%

26-Week Price Return-13.09%

Quick Ratio (Annual)3.21x

13-Week Price Return-15.17%

Total Debt / Equity (Annual)0.44x

Current Ratio (Quarterly)3.90x

Enterprise Value$9,272.732

Revenue / Share Growth (5Y)3.04%

Asset Turnover (TTM)0.35x

Book Value / Share Growth (5Y)6.64%

Revenue / Employee (Annual)$0

Inventory Turnover (Annual)2.61x

Pretax Margin (Annual)23.46%

Cash / Share (Annual)$5.07

3-Month Return Std Dev42.01%

Gross Margin (5Y Avg)63.87%

Net Income / Employee (TTM)$0

EBITDA CAGR (5Y)-2.06%

EBITDA Interim CAGR (5Y)-18.40%

ROE (Last FY)11.25%

Net Interest Coverage (Annual)36.97x

EPS Basic Excl Extra (Annual)$1.94

P/FCF (TTM)18.91x

Receivables Turnover (TTM)5.38x

EV / Free Cash Flow (TTM)20.74x

Total Debt / Equity (Quarterly)0.44x

EPS Incl Extra (TTM)$2.00

Receivables Turnover (Annual)5.38x

ROI (TTM)8.10%

P/S Ratio (TTM)4.05x

Pretax Margin (5Y Avg)20.64%

Revenue / Share (Annual)$9.56

Tangible BV / Share (Annual)$15.66

Forward P/E16.32x

Free OCF CAGR (5Y)23.83%

Price vs S&P 500 (52W)-33.82%

P/E Ratio (TTM)19.91x

EPS Growth TTM (YoY)447.53%

Year-to-Date Return-8.74%

5-Day Price Return-1.72%

EPS Normalized (Annual)$1.94

ROA (5Y Avg)5.78%

Net Profit Margin (Annual)20.33%

Month-to-Date Return2.50%

Cash Flow / Share (TTM)$2.35

EBITD / Share (Annual)$2.15

EPS Growth (3Y)0.85%

Operating Margin (Annual)22.17%

LT Debt / Equity (Annual)0.44x

P/CF (TTM)12.93x

ROI (5Y Avg)6.81%

P/E Excl Extra (TTM)19.91x

LT Debt / Equity (Quarterly)0.44x

EPS Basic Excl Extra (TTM)$2.00

P/TBV (Quarterly)2.88x

Payout Ratio (Annual)12.77%

P/B Ratio (Annual)2.58x

Inventory Turnover (TTM)2.66x

Pretax Margin (TTM)23.46%

Book Value / Share (Annual)$17.45

Price vs S&P 500 (13W)-17.55%

Net Margin Growth (5Y)1.15%

Beta0.80x

P/FCF (Annual)18.91x

Revenue / Share (TTM)$9.57

ROE (TTM)11.85%

52-Week Low$38.80

Analyst Recommendations

Jan 2026

Feb 2026

Mar 2026

Apr 2026

3.63

3.58

3.63

About

Qiagen develops proprietary sample preparation and diagnostic solutions serving life sciences research and molecular diagnostics equally. The business model generates roughly 90% of revenue from consumables, with the remainder from instruments and services. North America represents the largest market (52% of 2024 sales), followed by EMEA (33%) and Asia-Pacific (15%).